| Market revenue in 2023 | USD 206.5 million |
| Market revenue in 2030 | USD 418.0 million |
| Growth rate | 10.6% (CAGR from 2023 to 2030) |
| Largest segment | Ballon sinus dilation devices |
| Fastest growing segment | Functional Endoscopic Sinus Surgery (FESS) Instruments Set |
| Historical data | 2016 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Ballon Sinus Dilation Devices, Endoscopes, Sinus Stents/Implants, Functional Endoscopic Sinus Surgery (FESS) Instruments Set |
| Key market players worldwide | Medtronic PLC, Smith & Nephew PLC, Stryker Corp, Intersect ENT, Olympus Corp, Johnson & Johnson, TE Connectivity Ltd, SinuSys Corp., InnAccel |
Demand for sinus dilation device in Canada has been reported to be increasing prevalence of Chronic Rhinosinusitis (CRS). Technological advancements and a number of product launches are also anticipated to drive the sinus dilation device market in Canada.
For instance, according to an independent study published in JAMA Otolaryngology-Head & Neck Surgery, in 2016, the prevalence of CRS was 3.4% in men and 5.7% in women. The report further states that 2.5% of the Canadian population were diagnosed with CRS and the mean incidence was 2.5 per 1000 population in 2016.
Furthermore, technological developments in sinus dilation devices in the past few years has increased the adoption rate among the end-users. The existence of different technologically advanced options for the patients suffering from frequent sinus pain will affect the sinus dilation device market growth in the near future.
Publish Date: -
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Johnson & Johnson | View profile | 134,400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | www.jnj.com |
| Medtronic PLC | View profile | 95,000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | www.medtronic.com |
| Stryker Corp | View profile | 52,000 | 1941 Stryker Way, Portage, MI, United States, 49002 | www.stryker.com |
| Olympus Corp | View profile | 33,629 | Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, Japan, 163-0914 | www.olympus.co.jp |
| Smith & Nephew PLC | View profile | 18,452 | Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE | www.smith-nephew.com |
| TE Connectivity Ltd | View profile | 90,000 | Muhlenstrasse 26, Schaffhausen, Switzerland, CH-8200 | www.te.com |
| Intersect ENT | View profile | 251-500 | Menlo Park, California, United States, North America | www.intersectent.com |
| SinuSys Corp. | View profile | 1-10 | Palo Alto, California, United States, North America | www.sinusys.com |
| InnAccel | View profile | 11-50 | Bangalore, Karnataka, India, Asia | www.innaccel.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Sinus Dilation Device Market Outlook will help companies and investors design strategic landscapes.
Ballon Sinus Dilation Devices was the largest segment with a revenue share of 47.31% in 2023.
Horizon Databook has segmented the Canada sinus dilation device market based on ballon sinus dilation devices, endoscopes, sinus stents/implants, functional endoscopic sinus surgery (fess) instruments set covering the revenue growth of each sub-segment from 2016 to 2030.
Demand for sinus dilation device in Canada has been reported to be increasing prevalence of Chronic Rhinosinusitis (CRS). Technological advancements and a number of product launches are also anticipated to drive the sinus dilation device market in Canada.
For instance, according to an independent study published in JAMA Otolaryngology-Head & Neck Surgery, in 2016, the prevalence of CRS was 3.4% in men and 5.7% in women. The report further states that 2.5% of the Canadian population were diagnosed with CRS and the mean incidence was 2.5 per 1000 population in 2016.
Furthermore, technological developments in sinus dilation devices in the past few years has increased the adoption rate among the end-users. The existence of different technologically advanced options for the patients suffering from frequent sinus pain will affect the sinus dilation device market growth in the near future.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada Sinus Dilation Device Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Canada Sinus Dilation Device Market Outlook from 2016 to 2030, including revenue numbers, major trends, and company profiles.
